Docstoc

MSU Cancer

Document Sample
MSU Cancer Powered By Docstoc
					MSU Cancer Treatment Consortium (MSUCTC): Clinical oncology research at MSU has been conducted through the MSUCTC. Encompassing eight communities and most of Michigan’s rural and farming areas, the MSUCTC was established in 1975 by Nikolay V. Dimitrov, M.D., Professor of Medicine and Deputy Director of the Cancer Center at MSU. As a result of Dr. Dimitrov’s development of this cancer treatment network, the MSUCTC has participated in the National Surgical and Adjuvant Breast and Bowel Project (NSABP) since 1976. Dr. Aaron Schonik is the Principal Investigator of the NSABP. The cities from which the consortium actively enrols patients onto clinical protocols include: Lansing, Jackson, Flint, Saginaw, Port Huron, Marquette, Kalamazoo, and Grand Rapids (See Figure 1). The MSUCTC has been a program of interdisciplinary collaboration among clinical investigators since its inception. All six of the CHM campuses have been active participants in the clinical cancer research of MSU since the MSU Cancer Treatment Consortium was initiated. Great Lakes Cancer Institute (GLCI): The GLCI has now assumed leadership of the MSUCTC. Dr. Robert Hall has joined the Department of Medicine and is Clinical Director of Medical Oncology as well as the Director of the GLCI. GLCI was established in June 2001 to integrate the research and educational resources of MSU with the facilities and professional staff of McLaren Health Care. Through this collaboration, GLCI delivers superior cancer care through a highly skilled team of clinicians, researchers, and educators dedicated to community-based networking. Its mission includes serving the people of Michigan and beyond as a leading resource for cancer patient care and education; conducting significant cancer research and contributing to the advancement of knowledge in cancer causation, prevention, and treatment; translating research findings to patient care as soon as possible; and providing cancer leadership of national renown. The Behavior Cooperative Oncology Group (BCOG): The mission of BCOG is to provide leadership in the development of a collaborative group of behavioral researchers, committed to fostering the development of behavioral oncology research across the cancer continuum. As part of the executive committee of BCOG, funded through the Walther Cancer Institute, Dr. C. Given has a working association with cancer academic researchers, oncology professionals, and cancer center agencies in the Midwest. The BCOG affiliates include behavioral researchers from MSU, Indiana University, University of Michigan, Ohio State University, and Duke University.

BRESLIN CANCER CENTER, INGHAM REGIONAL MEDICAL CENTER Breslin Cancer Center is a full-service, community-based outpatient cancer care facility in Lansing, Michigan. The patient focused services provided include an interdisciplinary team approach for coordinated, comprehensive, individualized treatment planning and delivery; dedicated chemotherapy outpatient infusion center with certified infusion nurses; on-site pharmacist with oncology expertise; on-site clinical trials coordinator who works with providers and patients to identify opportunities to participate in clinical trials; a Patient Resource Center that offers patients and their families current information and resources through videos, literature, and internet searches; and supportive services and referrals for needed nutritional social work, and pastoral consultations. Breslin Cancer Center’s participation in nationally sponsored clinical trials through MSU Cancer Treatment Consortium SWOG, RTOG, and NSABP, bring state of the art cancer care to mid-Michigan residents. The recent partnership between MSU and McLaren Health Care Cooperation blends the resources of a premier academic institution and a leading health care system, of which IRMC is affiliated, to bring a wealth of knowledge to advance both the art and science of cancer medicine. The MSU hematology and oncology services and the IRMC – based hematology and oncology practices, coming together in the Breslin Cancer Center, will increase the access to state of the art cancer care and research.

MSU CANCER CENTER, INGHAM REGIONAL MEDICAL CENTER (IRMC) MSU Cancer Center is a full-service, community-based outpatient cancer care facility in Lansing, Michigan. The patient focused services provided include an interdisciplinary team approach for coordinated, comprehensive, individualized treatment planning and delivery; dedicated chemotherapy outpatient infusion center with certified infusion nurses; on-site pharmacist with oncology expertise; on-site clinical trials coordinator who works with providers and patients to identify opportunities to participate in clinical trials; a Patient Resource Center that offers patients and their families current information and resources through videos, literature, and internet searches; and supportive services and referrals for needed nutritional, social work, and pastoral consultations. The MSU Cancer Center’s participation in nationally sponsored clinical trials (SWOG, RTOG, and NSABP) through the MSU Cancer Treatment Consortium, bring state of the art cancer care to midMichigan residents. Recently, MSU and McLaren Health Care Cooperation partnered to form the Great Lakes Cancer Institute which blends the resources of a premier academic institution and a leading health care system, of which IRMC is affiliated, to bring a wealth of knowledge to advance both the art and science of cancer medicine.


				
DOCUMENT INFO